Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
14.80
-0.22 (-1.46%)
At close: May 15, 2026, 4:00 PM EDT
14.79
-0.01 (-0.07%)
After-hours: May 15, 2026, 5:59 PM EDT
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $27.7 million as of May 15, 2026. Its market cap has increased by 1,506.80% in one year.
Market Cap
27.70M
Enterprise Value
15.43M
1-Year Change
1,506.80%
Ranking
Category
Stock Price
$14.80
Market Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $27.70M, an increase of 326.16%. That is a compound annual growth rate of 155.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 27.70M | 104.72% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quantum BioPharma | 32.55M |
| Palatin Technologies | 32.25M |
| NeuroSense Therapeutics | 30.95M |
| Skye Bioscience | 30.94M |
| BriaCell Therapeutics | 30.28M |
| Apollomics | 30.24M |
| Tempest Therapeutics | 29.84M |
| IGC Pharma | 29.39M |